What’s happening with TikTok?
As many of you have heard, TikTok has been formally banned in the U.S. (it will take effect by January 2025 at the earliest). The major reason for the ban is the national security threat from the Chinese government, which could potentially use it to spy on Americans or weaponize it to covertly influence the U.S. public by amplifying or suppressing certain content. While TikTok management is willing to fight the ban in court and looking for various workarounds, it is forecasted that the platform will most likely be purchased by one of the U.S. tech companies. Under the bill, TikTok will now have 270 days to divest. However, an additional provision could also see TikTok apply for an extra three months under certain conditions (e.g., if it’s negotiating with buyers and needs more time to finalize the deal).
We already see conversations around potential platform buyers. Experts say that Meta is the least likely candidate in this case, and it is more realistic to consider companies such as Oracle, Microsoft, Walmart, and Triller.
What does it mean for us as pharma marketers?
It is hard to predict how the platform will evolve if TikTok wins its legal case or if either of the players acquires it. This means it is too early for pharma marketers to consider future strategic considerations.
Regardless of the outcome, it’s obvious that the situation casts a shadow on the platform’s reputation in the eyes of pharmaceutical marketing stakeholders who were considering it for potential social initiatives. It also may affect the U.S. social media landscape, where we can expect a spike in snackable video content on Instagram Reels or YouTube Shorts driven by migrated U.S. influencers.
We haven’t had a chance to produce any content for the platform in the past due to regulatory implications on our clients’ side. However, we are currently working on Instagram and Facebook Reel ads development for clients, which is a great opportunity to start exploring the format deeper as an alternative to TikTok.
When considering influencer marketing, it would be fair to eliminate TikTok as a platform for potential partnerships and focus on Instagram and YouTube. X (former Twitter) is a questionable platform for HCP influencers as it is still experiencing some market backlash and had a 7% drop in brand use in 2024.
The upcoming changes aren’t supposed to significantly affect the way we’ve been strategizing our clients’ social presence. However, we should keep exploring alternative platforms to help brands engage effectively with patient/HCP audiences while keeping a close eye on the next steps on the TikTok side. As an agency committed to staying ahead of the curve, we’re prepared to navigate these changes alongside our clients and help them thrive in the evolving social media landscape.